Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Dorian Therapeutics logo — Younger, for longer.

Dorian Therapeutics

Younger, for longer.

Founded 2018 United States San Carlos, United States 7 employees Seed Health Care

General Information

Company Name Dorian Therapeutics
Founded Year 2018
Location United States San Carlos, United States +1
Employees 7
Industries Health Care
Funding Stage Seed
Social

Get notified when Dorian Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Dorian Therapeutics

Dorian Therapeutics is a health care startup founded in 2018 and based in the United States. The company's slogan, "Younger, for longer," reflects its focus on anti-aging technology.

Specializing in the development of senoblockers, a new class of therapeutics, Dorian Therapeutics aims to disrupt aging by blocking senescence while reactivating tissue regeneration. This innovative approach has attracted the attention of prominent investors.

In August 22, 2018, the company successfully secured seed round investment from Y Combinator and Viva BioInnovator, demonstrating confidence in the potential of its groundbreaking technology.

This strategic investment not only provides financial support for Dorian Therapeutics' research and development efforts but also serves as a testament to the company's viability and promise within the health care industry.

Taxonomy: anti-aging, senoblockers, therapeutics, age-associated diseases, regeneration capacity, diabetes treatment, alzheimer's treatment, arthritis treatment, sarcopenia treatment, osteoarthritis treatment, osteoporosis treatment, cellular therapy, immunotherapy, senescence, tissue regeneration

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor Investor
22 Aug 2018

Dorian Therapeutics Alternatives & Competitors

Dorian Therapeutics vs
AnteAGE
AnteAGE United States

Growth Factors & Cytokines

42 employees
Manufacturing, Retail
Dorian Therapeutics vs
GOLIVER THERAPEUTICS
GOLIVER THERAPEUTICS France

Repair the liver without graft

Grant
31 employees
Biotechnology
Dorian Therapeutics vs
Jade Therapeutics
Jade Therapeutics

Enhancing corneal healing with sustained-release therapeutics for improved visual function and quali...

Grant
Biotechnology, Health Care
Also compare with: Dorian Therapeutics vs Kovina Therapeutics Kovina Therapeutics

FAQ About Dorian Therapeutics

Younger, for longer.
Dorian Therapeutics was founded in 2018.
Dorian Therapeutics is headquartered in San Carlos, United States.
Dorian Therapeutics operates in the following industries: Health Care.
Dorian Therapeutics has approximately 7 employees.
Dorian Therapeutics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Dorian Therapeutics include AnteAGE, GOLIVER THERAPEUTICS, Jade Therapeutics, Kovina Therapeutics, DermBiont, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Dorian Therapeutics and AnteAGE are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Dorian Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy